Cuso.ch
Tropheryma whipplei Bacteremia during Feverin Rural West Africa
Florence Fenollar,1 Oleg Mediannikov,1,2 Cristina Socolovschi,1 Hubert Bassene,2 Georges Diatta,2 Herve´ Richet,1
Adama Tall,3 Cheikh Sokhna,2 Jean-Franc¸ois Trape,2 and Didier Raoult1,2
Unite´ de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Universite´ de la Me´diterrane´e, Faculte´ de Me´decine,1Marseille, France, and 2Dakar, Se´ne´gal; and 3Institut Pasteur de Dakar, Dakar, Se´ne´gal
(See the editorial commentary by Greub, on pages 522–524.)
Tropheryma whipplei not only causes Whipple disease but also is an emerging pathogen associated
with gastroenteritis and pneumonia that is commonly detected in stool samples in rural West Africa. We investigatedthe role of
T. whipplei in febrile patients from rural Senegal who had a negative test result for malaria.
From November 2008 through July 2009, we conducted a prospective study in 2 Senegalese villages;
204 blood specimens from febrile patients were collected. DNA extraction of whole-blood samples collected byfinger pricks with a lancet stick was performed in Senegal; elution and quantitative polymerase chain reactionassays for
T. whipplei were performed in France. In April 2009, we conducted a screening to look for the presenceof
T. whipplei in the saliva and stools of the overall population. Blood from French patients with chronic
T. whippleiin stool samples was also analyzed.
The presence of
T. whipplei DNA was detected in blood from 13 (6.4%) of 204 tested patients, mostly
in children and in December and January. None of the French carriers tested positive. The patients with
T. whippleibacteremia presented with fever (13 patients), cough (10), thirst (8), fatigue (7), rhinorrhea (6), and sleep disorders
(5). Cough and sleep disorders were significantly more frequent in febrile carriers than in the 191 febrile episodeswithout
T. whipplei bacteremia (
P p .002 and .005, respectively). No correlation was observed between the presenceof
T. whipplei in the stools and saliva and bacteremia.
Our findings suggest that
T. whipplei is an agent of unexplained cold season fever with cough
in rural West Africa.
Until recently,
Tropheryma whipplei was thought to be
itis, and pneumonia [1, 3, 4, 6–8]. The bacterium is
a rare bacterium typically causing the classic form of
also highly prevalent (15%) in fecal samples obtained
Whipple disease, which is characterized by histologic
from children aged 2–4 years in France who have gas-
periodic acid–Schiff–stained bacilli in infected small-
troenteritis but was not detected in samples from a
bowel macrophages [1, 2]. However, this well-known
control group of children of the same age without di-
entity, described mainly in white men, represents only
arrhea [9].
T. whipplei DNA has also been detected in
1 rare clinical manifestation of
T. whipplei infection.
stool and saliva specimens from asymptomatic individ-
Indeed, recent studies have shown that the spectrum
uals, but its prevalence depends on the geographic area
of infections due to
T. whipplei is wide [1, 3–5] because
[10, 11]. In Europe, the prevalence of this bacterium
this bacterium can cause localized infections, such as
in fecal samples from the healthy general adult popu-
endocarditis, spondylodiskitis, meningoencephalitis, uve-
lation is estimated to be 1%–11% [1]. In addition, thebacterium has been detected in sewage and is moreprevalent in fecal samples of sewer workers (12%–26%)
Received 17 March 2010; accepted 29 April 2010; electronically published 26
than in the general population [12–14]. In a recent
Reprints or correspondence: Prof Didier Raoult, Unite´ de Recherche en Mal-
study, 44% of children aged 2–10 years who live in
adies Infectieuses et Tropicales Emergentes (URMITE), UMR CNRS-IRD 6236–198,
rural Senegal carried
T. whipplei in their stool samples
Faculte´ de Me´decine, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France(
[email protected]).
[15]. Water from all 8 village wells have tested negative
Clinical Infectious Diseases
for
T. whipplei by polymerase chain reaction (PCR)
2010 by the Infectious Diseases Society of America. All rights reserved.
[15]. This research was part of a longitudinal study of
the host-parasite relationship in 2 Senegalese villages,
T. whipplei Bacteremia •
CID 2010:51 (1 September) • 515
which was initiated in 1990 and focused initially on malaria
washing with Buffer AW2 and incubation at room tempera-
and tickborne borreliosis [16, 17]. Improvements in the knowl-
ture for 5 min with 100 mL of Buffer AE, DNA was eluted by
edge and management of these diseases have led us to extend
centrifugation at 6000
g for 1 min.
our studies to look for other etiologic agents of fever. Because
Master mixtures were prepared by following the manufac-
T. whipplei is highly prevalent in human stool samples obtained
turer's instructions. Quantitative real-time PCR was performed
in rural Senegal and is also an agent of gastroenteritis [9], we
using a LightCycler instrument (Roche Diagnostics) with the
first hypothesized that
T. whipplei gastroenteritis may corre-
QuantiTect Probe PCR Kit as described by the manufacturer.
spond to a primo-infection and that there was bacteremia in
First, specimens were tested using the Twhi3F: 5-TTGTGTA-
patients who presented with fever [9]. Thus, our aim was to
TTTGGTATTAGATGAAACAG-3 and Twhi3R: 5-CCCTACA-
investigate the potential of
T. whipplei to cause infection in
ATATGAAACAGCCTTTG-3 primer pair and the specific
patients with unknown fever and a negative test result for ma-
TaqMan probe Twhi3: 6-FAM-GGGATAGAGCAGGAGGTGT-
laria in rural Senegal.
CTGTCTGG-TAMRA, as previously reported [8]. When thespecimen tested positive in this assay, the result was confirmed
PATIENTS, MATERIALS, AND METHODS
by a second quantitative PCR using the Twhi2F: 5-TGAGGAT-
GTATCTGTGTATGGGACA-3 and Twhi2R: 5-TCCTGTTAC-
In 2008 and 2009, we performed
AAGCAGTACAAAACAAA-3 primer set and the Twhi2 probe:
studies among the population of Dielmo (1343N, 1625W)
6-FAM-GAGAGATGGGGTGCAGGACAGGG-TAMRA. A case
and Ndiop (1433N, 1615W), 2 villages in the Sine-Saloum
was defined as 2 positive quantitative PCR results in assays
region of Senegal, to assess the incidence of
T. whipplei. These
targeting 2 different
T. whipplei repeated DNA sequences. The
villages are included in the Dielmo project, a longitudinal pro-
quality of DNA handling and extraction of blood samples was
spective study initiated in 1990 for long-term investigation of
verified by quantitative PCR for a housekeeping gene coding
host-parasite associations [16, 17]. In 2009, the survey showed
for b-actin, as previously described [18].
a population of 391 in Dielmo (ratio of female to male subjects,
Stool and saliva analysis.
In April 2009 we looked for
T.
1.04:1), of which 35% were children younger than 10 years,and a population of 313 in Ndiop (ratio of female to male
whipplei in stool and saliva of the overall population, as pre-
subjects, 1.1:1), of which 36.5% were children aged
viously done and reported in April 2008 [16]. We also sampled
At the beginning of the study, all members of the population,
stool samples from patients when they developed diarrhea. Af-
including patients and parents or legal guardians of all children,
ter collection, each fecal specimen was mixed with 2.5 mL of
gave written individual informed consent. The national ethics
absolute ethanol and each saliva specimen with 1 mL of absolute
committee of Senegal and the local ethic committee of the
ethanol for storage and transportation to our laboratory at
Institut Fe´de´ratif de Recherche 48 (Marseille, France) approved
room temperature. On arrival, DNA was extracted using the
this study. Detection of individuals with fever was both passive
BioRobot MDx workstation (Qiagen) in accordance with the
and active. The dispensary created for the project was open 7
manufacturer's recommendations and protocols.
T. whipplei
days a week. Every villager was also visited daily at home for
quantitative PCR assays were performed as described herein.
clinical monitoring. For individuals with fever (defined as an
A case was defined as 2 positive quantitative PCR results in
axillary temperature 137.5C), a medical attendant completed
assays targeting 2 different
T. whipplei DNA sequences.
a medical examination and a thick blood film.
Blood control group.
Ten blood specimens received in our
Whole-blood samples were collected from
laboratory for routine diagnostic purposes [19] sampled in an
finger pricks using a lancet stick and applied to glass microscope
EDTA tube before DNA extraction and negative for
T. whipplei
slides. Thick and thin blood smears were stained with Giemsa
were tested by quantitative PCR b-actin as previously described
and analyzed by microscopy for trophozoites and gametocytes
[18]. Data from 18 patients with chronic asymptomatic
T. whip-
of malaria and
Borrelia. If the malaria test result was negative,
plei in the stool previously identified by our team [12] and
200 mL (3–4 drops) of whole blood was collected for DNA
followed up for 4 years by one of us (D.R.) in consultation
were also included for comparisons. Sixty blood specimens
The first step of DNA extraction was done directly in the
sampled in EDTA tubes for 4 years from these 18 patients were
village dispensary using QIAamp kits (QIAGEN). The whole
tested for
T. whipplei using quantitative PCR as previously de-
blood was digested with the supplied proteinase K. Then bind-
scribed [19].
ing and washing of samples with Qiagen columns were per-
Data were analyzed using EpiInfo soft-
formed with an adapted 35-mL PVC manual pump (Fisher
ware, version 3.4.1 (Centers for Disease Control and Preven-
Scientific). Next, the columns with the bound and dried DNA
tion). Nonparametric values were compared using the x2 test.
inside were stored at +4C before final elution performed later
Statistical significance was defined as
P values !.05. The cor-
at the Unite des Rickettsies, Marseille, France. After repeated
rected x2 test or the Fisher exact test was used when indicated.
516 •
CID 2010:51 (1 September) • Fenollar et al
Figure 1.
Map illustrating the location of Senegal and the villages of Dielmo and Ndiop and the number of samples positive for
Tropheryma whipplei
in this study.
6.9 for 10 blood specimens received in our laboratory for rou-
tine diagnostic purposes and sampled in an EDTA tube before
From December 2008 to July 2009, 204 blood
DNA extraction. The difference was not significant (
P p .77)
samples from 134 patients (62 male and 72 female patients)
between these 2 ways of sampling.
were analyzed and included in this study; 103 (77%) were from
The prevalence of
T. whipplei–positive samples was 6.4% (13
Dielmo (391 inhabitants) and 31 (23%) were from Ndiop (313
of 204). The proportion of positive samples was 0 of 4 in
inhabitants). Ninety (67.2%) were aged !10 years, including64 (47.8%) who were aged
November, 3 (14.3%) of 21 in December; 7 (16.6%) of 42 in
!5 years. No one died during the
January, 0 of 7 in February, 0 of 25 in March, 3 (16.7%) of 18
Thirteen patients (Figures 1 and 2) tested positive for
T.
in April, 0 of 16 in May, 0 of 29 in June, and 0 of 42 in July.
whipplei according to our criteria. Furthermore, the b-actin
The prevalence was significantly higher in children aged !10
gene amplification by quantitative PCR was highly positive for
years (10 of 252) than in older people (3 of 452;
P p .003).
all specimens, confirming the quality of the extracted DNA.
The prevalence was also significantly higher in Dielmo (12 [3%]
Indeed, the mean number of cycles ( standard deviation
of 391) than in Ndiop (1 [0.3%] of 313;
P p .007) and in both
[SD]) of the cycles was 25 2.85 for all of the blood specimens
December and January (10 [15.9%] of 63) than during the
directly sampled for DNA extraction in Senegal and 26.19 -
other months (3 [2.1%] of 141;
P ! .001).
Figure 2.
Summary of the 13 patients (coded as A–M) with
Tropheryma whipplei–positive DNA on blood focusing on the seasonality of the bacteremia
and the
T. whipplei polymerase chain reaction data from saliva and stool performed at the time of systematic screening in April 2008 and 2009 butalso during an episode of diarrhea for 2 patients in January 2009.
T. whipplei Bacteremia •
CID 2010:51 (1 September) • 517
Epidemiologic and Clinical Characteristics of the 13 Patients with Tropheryma whipplei Bacteremia and Results of the
Systematic Screening to Look for T. whipplei in Stool and Saliva Specimens, April 2009.
Clinical symptoms
stool; for saliva
Cough, rhinorrhea
Negative; negative
Headache, thirst, fatigue, sleep disorders
Headache, fatigue, cough
Headache, fatigue, cough, rhinorrhea
Negative; negative
Low appetite, diarrhea, cough
Headache, fatigue, cough, rhinorrhea
Headache, thirst, low appetite, fatigue, cough,
Positive; negative
rhinorrhea, sleep disorders
Cough, rhinorrhea
Positive; negative
Sleep disorders, fatigue, headache, low
Headache, sleep disorders, low appetite,
Negative; negative
thirst, fatigue, rhinorrhea
Low appetite, cough, sleep disorders, vomiting
NA, not available.
The main clinical characteristics of the patients who were
45 males and 41 females aged 7 months to 79 years (mean
positive for
T. whipplei are summarized in Table 1. Five patients
SD, 913.3 years). The data are summarized in Table 3.
were male and 7 were female. Patients were aged 7 months to
Among the 13 patients with
T. whipplei bacteremia, stool sam-
49 years, with a mean age (SD) of 10.7 16.3 years, a median
ples were analyzed for 10 (Figures 1 and 2). Among these 10
age of 3 years, and an interquartile range of 9 years. Their main
patients, 4 also had a positive PCR result in stool samples,
clinical manifestations were cough (reported by 10 patients),
whereas 6 had negative results. Twenty-five patients with neg-
thirst (8 patients), headache (7 patients), rhinorrhea (6 pa-
ative
T. whipplei PCR results in blood specimens had a positive
tients), fatigue (5 patients), sleep disorders (5 patients), and
stool
T. whipplei PCR result at the time of the systematic screen-
loss of appetite (3 patients). Only 1 patient presented withvomiting and 1 with diarrhea. All the patients were treated with
Comparison of the Main Clinical Characteris-
tics of 13 Patients with Tropheryma whipplei Bacteremia
acetominophen; only 1 received antibacterial therapy with tri-
and of 191 Patients without T. whipplei Bacteremia
methoprim-sulfamethoxazole. When compared with the 191episodes without
T. whipplei bacteremia, cough and sleep dis-
No. (%) of patients
orders are significantly more frequent in patients with
T. whip-
plei DNA in their blood (
P p .002 and
P p .005, respectively)
Six patients presented with new episodes of fever after
T.
whipplei bacteremia, nearly 2 months later for 5 patients and
7 months later for 1 patient. Other blood specimens were also
available. All
T. whipplei PCR assay results were negative for 5
patients. For 1 patient,
T. whipplei DNA was only slightly de-
tected in 1 of the 2 specific PCR assays 2 months later; however,
7 months later both PCR assay results were negative. None of
the blood specimens from the 18 French patients who were
chronic asymptomatic carriers of
T. whipplei were positive for
T. whipplei.
Analysis of stool and saliva specimens.
Of the 134 patients
analyzed in this study, stool samples were also sampled for 86
at the time of systematic screening in Spring 2009, including
Diarrhea was defined as 13 liquid stools per day.
518 •
CID 2010:51 (1 September) • Fenollar et al
Comparison of Number of Stool Samples Positive for Tropheryma whipplei and Number Tested
for Each Age Group, April 2008 and 2009
No. of positive stool samples / no. tested (%), by date and region
Data for April 2008 were extracted from our previous study [15].
ing. Seventeen were from Dielmo and 8 from Ndiop. Fifty-one
identified cases of rickettsioses [20], Q fever [18], and recurrent
patients with negative
T. whipplei PCR results in blood speci-
fever (unpublished data). To our knowledge, this study is the
mens also had a negative stool
T. whipplei PCR result at the
first attempt to investigate the presence of
T. whipplei in blood
time of the systematic screening. Forty-two were from Dielmo
specimens from patients with fever of uncertain origin. We
and 9 from Ndiop. Overall, no significant differences were
detected
T. whipplei DNA in 6.4% of blood samples from pa-
found between the presence of
T. whipplei in stool samples at
tients, primarily in children with fever in rural Senegal. We
the time of the screening and
T. whipplei bacteremia (
P p .45).
believe that our findings are reliable. The validity of the data
Furthermore, 33 patients tested for
T. whipplei bacteremia had
reported herein is based on strict experimental procedures and
a negative stool PCR result in 2008. Among these 33 patients,
controls, including rigorous positive and negative controls to
2 (1 from Ndiop and 1 from Dielmo) of 4 patients (1 from
validate the test. In addition, each positive PCR result was
Ndiop and 3 from Dielmo) who tested positive for
T. whipplei
confirmed by the successful amplification of an additional DNA
in their blood also tested positive for
T. whipplei in their stools
in 2009, whereas 5 (4 from Ndiop and 1 from Dielmo) of 29
In a previous study, we found that 44% of asymptomatic
patients (21 from Dielmo and 8 from Ndiop) who tested neg-
children aged 2–10 years who lived in rural Senegal carried
T.
ative for
T. whipplei in their blood had positive results for
T.
whipplei in their stool samples [15]. This screening was per-
whipplei in their stool samples in 2009. This difference was not
formed in April 2008. Herein, we confirm these results and
significant (
P p .18). Finally, 2 patients developed diarrhea in
extent our data to the carriage of
T. whipplei in saliva in older
January 2009.
T. whipplei DNA was detected in both stool sam-
children and adults. The prevalence observed in individuals
ples (Figure 1).
older than 10 years (18.2%) is lower than that in younger
Among the 134 patients analyzed in this study, saliva samples
individuals but higher than that observed in Europe [12, 14].
were collected for 51 at the time of the systematic screening in
In addition, this is the first time, to our knowledge, that
T.
April 2009, including 33 females and 18 males aged 11 months
whipplei in saliva has been detected in Senegal. The prevalence
to 79 years (mean SD, 15.4 18.5 years). The data are sum-
of salivary carriage of
T. whipplei (4%) is lower than that in
marized in Table 4. Among the 13 patients with
T. whipplei
stool but is still higher than that previously observed in the
bacteremia, saliva samples were analyzed for 7 patients from
general population in France (0.2%) and even in sewer workers
Dielmo. All test results were negative. Two patients from Ndiop
(2.2%) [12, 19]. As in previous studies, the 2 individuals with
with negative blood
T. whipplei PCR results had a positive saliva
T. whipplei PCR result at the time of the systematic screening.
Forty-two patients with negative blood
T. whipplei PCR results
Number of Saliva Samples Positive for Tropheryma
whipplei and Number Tested for Each Age Group, Spring 2009
also had a negative saliva
T. whipplei PCR result at the time ofthe systematic screening. Thirty-one were from Dielmo and 11
No. of positive saliva samples /
from Ndiop. No correlation was observed between
T. whipplei
no. tested, by region
infection and positive saliva
T. whipplei PCR results at the time
of the screening (
P p .74).
We are embarking on a large program of identification of the
bacterial agents causing fever in these 2 villages. We have already
T. whipplei Bacteremia •
CID 2010:51 (1 September) • 519
Figure 3.
Proposal of a natural cycle for
Tropheryma whipplei (Tw), including Tw bacteremia.
a PCR-positive saliva specimen also harbored
T. whipplei in
bacterium was detected in the bronchoalveolar lavage fluid of
stool samples [12, 19].
a child with pneumonia in the United States and in 6 (2.85%)
Although a seasonal variation for the detection of
T. whipplei
of 210 bronchoalveolar lavage fluid samples collected in patients
DNA in blood specimens of patients with fever of uncertain
with pneumonia in intensive care units in France, including 1
origin cannot be determined, significantly more cases were di-
case in which
T. whipplei was the only bacterium detected [7,
agnosed in the beginning of the dry season in December and
8]. These overall data undoubtedly raise questions about the
January (
P ! .001). Villagers from Dielmo had a significantly
role of
T. whipplei in the genesis of respiratory diseases with-
higher prevalence of
T. whipplei bacteremia than those of
out digestive involvement. It is currently difficult to locate
Ndiop. Interestingly, malaria [16], recurrent fever [17], Q fever
this bacteremia in the natural cycle of
T. whipplei infection.
[18], and fleaborne spotted fever [20] also had higher preva-
We propose several hypotheses (Figure 3).
lences in Dielmo than in Ndiop. The significant differences of
We did not test afebrile control subjects from Senegal, but
prevalence for these infectious diseases are commonly observed
the presence of
T. whipplei DNA in blood samples from ap-
in neighboring places but currently remain unexplained. The
parently healthy donors has been previously reported in a study
main classic clinical manifestations linked to
T. whipplei are
with 1 positive sample of 174 (0.6%) [21]. In another study,
arthralgia and diarrhea [1], but
T. whipplei has been reported
of 913 blood specimens tested by
T. whipplei PCR for patients
to involve nearly all organs [1]. Our hypothesis at the beginning
with an excluded diagnosis of
T. whipplei infection, none were
of this work was that primo-infection resulting in gastroenteritis
positive [19]. We may suspect that asymptomatic
T. whipplei
and fever [9] may be associated with bacteremia. However, we
bacteremia is more common in rural Senegal, where the bac-
were not able to link
T. whipplei bacteremia to diarrhea or to
terium is so common. This hypothesis should be addressed in
the presence of
T. whipplei in stool or saliva samples. However,
the future because the lack of blood specimens from asymp-
our 2 screenings were performed in the spring, whereas most
tomatic individuals in Dielmo and Ndiop is the main limitation
cases were observed in the winter.
of our study. However, the lack of bacteremia detected in French
Our work raises the question of the existence of a link be-
patients with chronic
T. whipplei goes against this theory.
tween the presence of
T. whipplei DNA in blood and the clinical
We confirm that children in rural Senegal are infected with
manifestations of infection. Herein, the major clinical sign of
T. whipplei at an early age. Our preliminary results suggest that
our patients was fever associated with cough.
T. whipplei has
T. whipplei may be associated with numerous undiagnosed in-
been recently suggested as an agent of pneumonia [7, 8]. The
fections with cough. We speculate that the distribution of
T.
520 •
CID 2010:51 (1 September) • Fenollar et al
whipplei is widespread and that the bacterium is an agent of
9. Raoult D, Fenollar F, Rolain JM, et al.
Tropheryma whipplei in children
with gastroenteritis. Emerg Infect Dis
2010; 16:776–782.
subtle, largely underestimated clinical manifestations, includ-
10. Dutly F, Altwegg M. Whipple's disease and
Tropheryma whippelii. Clin
ing respiratory infections.
Microbiol Rev
2001; 14:561–583.
11. Amsler L, Bauernfeind P, Nigg C, Maibach RC, Steffen R, Altwegg M.
Prevalence of
Tropheryma whipplei DNA in patients with various gas-
trointestinal disease and in healthy controls. Infection
2003; 31:81–85.
We thank the Cre´dit Ministe´riel "Programme Hospitalier de Recherche
12. Fenollar F, Trani M, Davoust B, et al. Carriage of
Tropheryma whipplei
Clinique" 2009 (Recherche de
Tropheryma whipplei comme agent de gastro-
in stools of sewer workers and human controls, but not in monkeys
ente´rite chez le jeune enfant).
and apes. J Infect Dis
2008; 197:880–887.
Cre´dit Ministe´riel "Programme Hospitalier de Re-
13. Maiwald M, Schuhmacher F, Ditton HJ, von Herbay A. Environmental
cherche Clinique" 2009.
occurrence of the Whipple's disease bacterium (
Tropheryma whippelii).
Potential conflicts of interest.
All authors: no conflicts.
Appl Environ Microbiol
1998; 64:760–762.
14. Schoniger-Hekele M, Petermann D, Weber B, Muller C.
Tropheryma
whipplei in the environment: survey of sewage plant influxes and sew-
age plant workers. Appl Environ Microbiol
2007; 73:2033–2035.
1. Fenollar F, Pue´chal X, Raoult D. Whipple's disease. N Engl J Med
15. Fenollar F, Trape JF, Bassene H, Sokhna C, Raoult D.
Tropheryma whipplei
in fecal samples from children, Senegal. Emerg Infect Dis
2009; 15:922–
2. Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult
D. Whipple's disease: new aspects of pathogenesis and treatment. Lan-
16. Trape JF, Rogier C, Konate L, et al. The Dielmo project: a longitudinal
cet Infect Dis
2008; 8:179–190.
study of natural malaria infection and the mechanisms of protective
3. Altwegg M, Fleisch-Marx A, Goldenberger D, Hailemariam S, Schaffner
immunity in a community living in a holoendemic area of Senegal.
A, Kissling R. Spondylodiscitis caused by
Tropheryma whippelii. Schweiz
Am J Trop Med Hyg
1994; 51:123–137.
Med Wochenschr
1996; 126:1495–1499.
17. Vial L, Diatta G, Tall A, et al. Incidence of tick-borne relapsing fever
4. Gubler JG, Kuster M, Dutly F, et al. Whipple endocarditis without overt
gastrointestinal disease: report of four cases. Ann Intern Med
1999; 131:
in west Africa: longitudinal study. Lancet
2006; 368:37–43.
18. Mediannikov O, Fenollar F, Socolovschi C, et al. Humans and ticks as
5. Drancourt M, Fenollar F, Denis D, Raoult D. Postoperative panophthal-
reservoirs of Q fever in rural Senegal. PLoS Negl Trop Dis
2010; 4:e654.
mitis caused by Whipple disease. Emerg Infect Dis
2009; 15:825–827.
19. Fenollar F, Laouira S, Lepidi H, Rolain J, Raoult D. Value of
Tropheryma
6. Rickman LS, Freeman WR, Green WR, et al. Uveitis caused by
Trophery-
whipplei quantitative PCR assay for the diagnosis of Whipple's disease:
ma whippelii (Whipple's bacillus). N Engl J Med
1995; 332:363–366.
usefulness of saliva and stool specimens for first line screening. Clin
7. Harris JK, De Groote MA, Sagel SD, et al. Molecular identification of
Infect Dis
2008; 47:659–667.
bacteria in bronchoalveolar lavage fluid from children with cystic fi-
20. Socolovschi C, Mediannikov O, Sokhna C, et al.
Rickettsia felis–associated
brosis. Proc Natl Acad Sci U S A
2007; 104:20529–20533.
uneruptive fever, Senegal. Emerg Infect Dis
2010; 16:1140–1142.
8. Bousbia S, Papazian L, Auffray JP, et al. Molecular analysis of bron-
21. Misbah SA, Stirzaker D, Ozols B, Franks A, Mapstone NP. Anonymous
choalveolar lavage in patients with pneumonia reveals the presence of
survey of blood donors by polymerase chain reaction for
Tropheryma
Tropheryma whipplei. Emerg Infect Dis
2010; 16:258–263.
whippelii. QJM
1999; 92:61.
T. whipplei Bacteremia •
CID 2010:51 (1 September) • 521
Source: https://www.cuso.ch/fileadmin/biologie_microbiologie/document/Fenollar_2010.pdf
February 2015 Year 11 No 80 Investments That Solve Inside This Issue: Initial Public Offerings Eco Securities Data Next Page - Left Mouse ClickPrevious Page - Right Mouse ClickExit Full Screen Mode - Escape Metro Performance Glass Eco Investor Mighty River Power 4, 11, 12, 35
Revision date 08-04-2016 Section 1: Identification of the substance/ mixture and of the company/ undertaking. 1.1 Product identifier 1.2 Relevant identified uses of the substances or mixture and uses advised against Laboratory chemicals, manufacture of substances, Scientific R&D 1.3 Details of the supplier of the safety data sheet Breckland Scientific Supplies Ltd